🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Several professionals said the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, marketing, and customer regulations, risking penalties, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the platform has removed violative content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or administering at residence.

Within moments of entering one community, a seller shared contact information, where most purchases occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Details and Costs

Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to possibly significant medical dangers”.